Record Detail Back
Procurement, Preservation and Allocation of Vascularized Organs
- Share to:
Patients developing end stage renal disease can be
treated by haemodialysis, peritoneal dialysis or transplantation.
Kidney transplantation is now generally accepted
as the primary therapy for chronic renal failure
in most patients, with the exception of those who
cannot tolerate immunosuppressive treatment or transplant
surgery [1]. Many reasons justify the use of
kidneys from living donors. Although the overall short
and long term results for all donor categories have
increased in recent years, transplants from living
related donors have a higher success rate than those
from cadaver donors [2]. In our experience with living
donor transplantation since 1966, survival of kidney
grafts from living donors is 20% higher at 10 years
than for those from cadaver donors. The introduction
of cyclosporin was responsible for increased survival
of all categories of transplants. In our series this
increase was 15% for cadaveric donors and 20% for
living donors. The benefit was more pronounced in
patients receiving kidneys from parents (+35%) and, in
this category, no effect of age was observed in the long
term analysis.
G.M. Collins, J.M. Dubernard, W. Land and G.G. Persijn - Personal Name
978-94-010-6280-0
NONE
Management
English
1997
1-372
LOADING LIST...
LOADING LIST...
